CONTROLLED RELEASE 25-HYDROXYVITAMIN D

The invention provides a pharmaceutical composition comprising an oral formulation of 25-hydroxyvitamin D3 for use in a method of treatment of secondary hyperparathyroidism in a human patient having chronic kidney disease. The method of treatment comprises administering the composition to the patien...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: White, Jay A, Bishop, Charles W, Crawford, Keith H, Petkovich, P. Martin, Messner, Eric J, Tabash, Samir P, Agudoawu, Sammy A
Format: Patent
Sprache:eng ; hun
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator White, Jay A
Bishop, Charles W
Crawford, Keith H
Petkovich, P. Martin
Messner, Eric J
Tabash, Samir P
Agudoawu, Sammy A
description The invention provides a pharmaceutical composition comprising an oral formulation of 25-hydroxyvitamin D3 for use in a method of treatment of secondary hyperparathyroidism in a human patient having chronic kidney disease. The method of treatment comprises administering the composition to the patient and the patient is treated without causing supraphysiological surges in blood levels of 25-hydroxyvitamin D3.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_HUE063590TT2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>HUE063590TT2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_HUE063590TT23</originalsourceid><addsrcrecordid>eNrjZFBz9vcLCfL38XF1UQhy9XF1DHZVMDLV9Yh0CfKPiAzzDHH09fRTcOFhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfEeoa4GZsamlgYhIUbGxKgBANQHJC0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>CONTROLLED RELEASE 25-HYDROXYVITAMIN D</title><source>esp@cenet</source><creator>White, Jay A ; Bishop, Charles W ; Crawford, Keith H ; Petkovich, P. Martin ; Messner, Eric J ; Tabash, Samir P ; Agudoawu, Sammy A</creator><creatorcontrib>White, Jay A ; Bishop, Charles W ; Crawford, Keith H ; Petkovich, P. Martin ; Messner, Eric J ; Tabash, Samir P ; Agudoawu, Sammy A</creatorcontrib><description>The invention provides a pharmaceutical composition comprising an oral formulation of 25-hydroxyvitamin D3 for use in a method of treatment of secondary hyperparathyroidism in a human patient having chronic kidney disease. The method of treatment comprises administering the composition to the patient and the patient is treated without causing supraphysiological surges in blood levels of 25-hydroxyvitamin D3.</description><language>eng ; hun</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240128&amp;DB=EPODOC&amp;CC=HU&amp;NR=E063590T2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240128&amp;DB=EPODOC&amp;CC=HU&amp;NR=E063590T2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>White, Jay A</creatorcontrib><creatorcontrib>Bishop, Charles W</creatorcontrib><creatorcontrib>Crawford, Keith H</creatorcontrib><creatorcontrib>Petkovich, P. Martin</creatorcontrib><creatorcontrib>Messner, Eric J</creatorcontrib><creatorcontrib>Tabash, Samir P</creatorcontrib><creatorcontrib>Agudoawu, Sammy A</creatorcontrib><title>CONTROLLED RELEASE 25-HYDROXYVITAMIN D</title><description>The invention provides a pharmaceutical composition comprising an oral formulation of 25-hydroxyvitamin D3 for use in a method of treatment of secondary hyperparathyroidism in a human patient having chronic kidney disease. The method of treatment comprises administering the composition to the patient and the patient is treated without causing supraphysiological surges in blood levels of 25-hydroxyvitamin D3.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFBz9vcLCfL38XF1UQhy9XF1DHZVMDLV9Yh0CfKPiAzzDHH09fRTcOFhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfEeoa4GZsamlgYhIUbGxKgBANQHJC0</recordid><startdate>20240128</startdate><enddate>20240128</enddate><creator>White, Jay A</creator><creator>Bishop, Charles W</creator><creator>Crawford, Keith H</creator><creator>Petkovich, P. Martin</creator><creator>Messner, Eric J</creator><creator>Tabash, Samir P</creator><creator>Agudoawu, Sammy A</creator><scope>EVB</scope></search><sort><creationdate>20240128</creationdate><title>CONTROLLED RELEASE 25-HYDROXYVITAMIN D</title><author>White, Jay A ; Bishop, Charles W ; Crawford, Keith H ; Petkovich, P. Martin ; Messner, Eric J ; Tabash, Samir P ; Agudoawu, Sammy A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_HUE063590TT23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; hun</language><creationdate>2024</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>White, Jay A</creatorcontrib><creatorcontrib>Bishop, Charles W</creatorcontrib><creatorcontrib>Crawford, Keith H</creatorcontrib><creatorcontrib>Petkovich, P. Martin</creatorcontrib><creatorcontrib>Messner, Eric J</creatorcontrib><creatorcontrib>Tabash, Samir P</creatorcontrib><creatorcontrib>Agudoawu, Sammy A</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>White, Jay A</au><au>Bishop, Charles W</au><au>Crawford, Keith H</au><au>Petkovich, P. Martin</au><au>Messner, Eric J</au><au>Tabash, Samir P</au><au>Agudoawu, Sammy A</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>CONTROLLED RELEASE 25-HYDROXYVITAMIN D</title><date>2024-01-28</date><risdate>2024</risdate><abstract>The invention provides a pharmaceutical composition comprising an oral formulation of 25-hydroxyvitamin D3 for use in a method of treatment of secondary hyperparathyroidism in a human patient having chronic kidney disease. The method of treatment comprises administering the composition to the patient and the patient is treated without causing supraphysiological surges in blood levels of 25-hydroxyvitamin D3.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; hun
recordid cdi_epo_espacenet_HUE063590TT2
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title CONTROLLED RELEASE 25-HYDROXYVITAMIN D
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-16T05%3A07%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=White,%20Jay%20A&rft.date=2024-01-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EHUE063590TT2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true